Company press releases

Displaying 101 - 114 of 114 results
Released Company Title Industry Topic
31 Dec 2021
07:01 CET 		CELYAD ONCOLOGY Celyad Oncology SA : Information relative au Nombre Total de Droits de Vote et d’Actions (Article 15 de la Loi du 2 Mai 2007) 20103010 Biotechnology Other subject
31 Dec 2021
07:01 CET 		CELYAD ONCOLOGY Celyad Oncology SA: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007) 20103010 Biotechnology Other subject
22 Dec 2021
07:02 CET 		CELYAD ONCOLOGY Celyad Oncology Announces January 2022 Conference Schedule 20103010 Biotechnology Other subject
22 Dec 2021
07:02 CET 		CELYAD ONCOLOGY Celyad Oncology annonce sa participation à une conférence en janvier 2022 20103010 Biotechnology Other subject
17 Dec 2021
22:01 CET 		CELYAD ONCOLOGY Celyad Oncology SA : Notification de Transparence de Tolefi SA (Article 14§1 de la loi du 2 mai 2007) 20103010 Biotechnology Other subject
17 Dec 2021
22:01 CET 		CELYAD ONCOLOGY Celyad Oncology SA: Transparency Notification Received from Tolefi SA and Related Persons (Article 14 §1 of the Law of 2 May 2007) 20103010 Biotechnology Other subject
15 Dec 2021
07:01 CET 		CELYAD ONCOLOGY Notification de Transparence de Fortress Investment Group LLC (Article 14§1 de la loi du 2 mai 2007) 20103010 Biotechnology Other subject
15 Dec 2021
07:01 CET 		CELYAD ONCOLOGY Transparency Notification Received From Fortress Investment Group LLC (Article 14 §1 of the Law of 2 May 2007) 20103010 Biotechnology Other subject
13 Dec 2021
07:01 CET 		CELYAD ONCOLOGY Celyad Oncology présente des mises à jour sur les programmes CAR-T basés sur la technologie ARNsh lors de la 63e assemblée et exposition annuelles de l’ASH 20103010 Biotechnology Other subject
13 Dec 2021
07:01 CET 		CELYAD ONCOLOGY Celyad Oncology Presents Updates on shRNA-Based CAR T Programs at the 63rd ASH Annual Meeting and Exposition 20103010 Biotechnology Other subject
08 Dec 2021
22:02 CET 		CELYAD ONCOLOGY Celyad Oncology Announces Closing of $32.5 Million Private Placement with Fortress Investment Group Affiliate 20103010 Biotechnology Other financial transaction
08 Dec 2021
22:02 CET 		CELYAD ONCOLOGY Celyad Oncology annonce la clôture du placement privé de 32,5 millions USD souscrit par une filiale de Fortress Investment Group 20103010 Biotechnology Other financial transaction
03 Dec 2021
07:31 CET 		CELYAD ONCOLOGY Celyad Oncology Announces $32.5 Million Private Placement With Fortress Investment Group 20103010 Biotechnology Other financial transaction
03 Dec 2021
07:31 CET 		CELYAD ONCOLOGY Celyad Oncology annonce un placement privé de 32,5 millions de dollars souscrit par Fortress Investment Group 20103010 Biotechnology Other financial transaction